Current Report Filing (8-k)
April 15 2015 - 4:05PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT
REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): April 9, 2015
BG Medicine, Inc.
(Exact
Name of Registrant as Specified in Its Charter)
001-33827
(Commission File Number)
|
|
|
Delaware |
|
04-3506204 |
(State or Other Jurisdiction Of Incorporation) |
|
(IRS Employer Identification No.) |
|
|
880 Winter Street, Suite 210, Waltham, Massachusetts |
|
02451 |
(Address of Principal Executive Offices) |
|
(Zip Code) |
(781) 890-1199
(Registrants Telephone Number, Including Area Code)
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any
of the following provisions (see General Instruction A.2. below):
¨ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 5.02. |
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
On April 9, 2015, Brian S. Posner notified BG Medicine, Inc. (the Company) that he was resigning from the Companys Board of Directors
(the Board), effective as of April 15, 2015. Mr. Posner did not communicate any disputes regarding the Companys operations, policies or practices to the Company in connection with this resignation, nor is the Company
aware of any. Stelios Papadopoulos, another member of the Companys Board, will fill the vacancy on the Companys Audit Committee created by Mr. Posners resignation.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
|
|
BG MEDICINE, INC. |
|
|
|
Date: April 15, 2015 |
|
|
|
/s/ Stephen P. Hall |
|
|
|
|
Stephen P. Hall Executive Vice President
& Chief Financial Officer |
BG Medicine (CE) (USOTC:BGMD)
Historical Stock Chart
From Jun 2024 to Jul 2024
BG Medicine (CE) (USOTC:BGMD)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about BG Medicine Inc (CE) (OTCMarkets): 0 recent articles
More Bg Medicine, Inc. News Articles